IRF5 and breast cancer: For the BC model, after t-dEV pre-conditioning with EVs isolated from 4T1 IRF5-low or 4T1 IRF5-high cells, mice were given IV injections of 4T1 cells for a purely metastatic model, and lungs were harvested 14 days later.